BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 25228535)

  • 1. Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.
    Clavo B; Robaina F; Jorge IJ; Cabrera R; Ruiz-Egea E; Szolna A; Otermin E; Llontop P; Carames MA; Santana-Rodríguez N; Sminia P
    Integr Cancer Ther; 2014 Nov; 13(6):513-9. PubMed ID: 25228535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
    Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
    Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.
    Combs SE; Thilmann C; Edler L; Debus J; Schulz-Ertner D
    J Clin Oncol; 2005 Dec; 23(34):8863-9. PubMed ID: 16314646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irradiation and bevacizumab in high-grade glioma retreatment settings.
    Niyazi M; Ganswindt U; Schwarz SB; Kreth FW; Tonn JC; Geisler J; la Fougère C; Ertl L; Linn J; Siefert A; Belka C
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):67-76. PubMed ID: 21030162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing incidence and improved survival of gliomas.
    Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
    Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
    J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
    Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
    Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in malignant gliomas].
    Ushio Y; Kochi M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence.
    Leonardi MA; Lumenta CB
    Minim Invasive Neurosurg; 2002 Dec; 45(4):201-7. PubMed ID: 12494354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.
    Narayana A; Yamada J; Berry S; Shah P; Hunt M; Gutin PH; Leibel SA
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):892-7. PubMed ID: 16458777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT).
    Combs SE; Gutwein S; Thilmann C; Debus J; Schulz-Ertner D
    Strahlenther Onkol; 2005 Dec; 181(12):768-73. PubMed ID: 16362786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis.
    Pinzi V; Orsi C; Marchetti M; Milanesi IM; Bianchi LC; DiMeco F; Cuccarini V; Farinotti M; Ferroli P; Finocchiaro G; Franzini A; Fumagalli M; Silvani A; Fariselli L
    Neurol Sci; 2015 Aug; 36(8):1431-40. PubMed ID: 25805705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.
    Chun SJ; Park SH; Park CK; Kim JW; Kim TM; Choi SH; Lee ST; Kim IH
    Radiother Oncol; 2018 Aug; 128(2):254-259. PubMed ID: 29937212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
    Klobukowski L; Falkov A; Chelimo C; Fogh SE
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord.
    Choi CY; Adler JR; Gibbs IC; Chang SD; Jackson PS; Minn AY; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):499-506. PubMed ID: 20133079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Franceschi E; Cavallo G; Lonardi S; Magrini E; Tosoni A; Grosso D; Scopece L; Blatt V; Urbini B; Pession A; Tallini G; Crinò L; Brandes AA
    Br J Cancer; 2007 Apr; 96(7):1047-51. PubMed ID: 17353924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution study.
    Hassler MR; Ackerl M; Flechl B; Sax C; Wöhrer A; Widhalm G; Dieckmann K; Hainfellner J; Preusser M; Marosi C
    Anticancer Drugs; 2014 Jul; 25(6):723-8. PubMed ID: 24441743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.